Keepin touch

Whether you have a question, comment, suggestion or any problem falling within the competence of the Government, send us your message and we will try to respond as soon as possible. If your problem does not fall within our competence, we will forward your message to the competent institution.

The Government of the Republic of Serbia

In the service of citizens

Prime Minister first one to receive vaccine against coronavirus

Belgrade, 24 December 2020

Prime Minister Ana Brnabic received today the first Pfizer-BioNTech vaccine against the coronavirus at the Torlak Institute for Virology, Vaccines and Serums.

Brnabic, who is the first European Prime Minister to receive the vaccine, pointed out that this day marks the beginning of the end of the coronavirus pandemic in Serbia, but also in Europe and the world.

As Prime Minister and as someone who leads the COVID-19 Crisis Response Team, I felt obliged to be the first to receive the vaccine, to show that we believe in it, as well as in our institutions, she stated.

Brnabic said that she agreed with President of the Republic Aleksandar Vucic that the two of them receive different vaccines, so he will most likely receive the next one that arrives, most probably the one produced by China.

At the moment we have the Pfizer-BioNTech vaccine, and the vaccines from the Chinese Sinopharm are expected in the near future, as well as certain quantities of the Russian vaccine Sputnik V.

She expressed her belief that at the end of the first quarter or the beginning of the second quarter of next year we will have the vaccine of the company AstraZeneca, and after that the vaccine manufactured by Moderna.

Brnabic pointed out that Serbia, not counting Great Britain, is the first country in Europe to receive the Pfizer-BioNTech vaccine, and the third to start a mass immunisation and campaign for giving the vaccine - after Great Britain and Switzerland.

She specified that our country will receive another 16,000 doses of Pfizer-BioNTech vaccine in January, as well as that together with other vaccines we will have a total of one million doses in January, and a total of approximately two million doses during the first quarter of next year.